Stress and breast cancer: from epidemiology to molecular biology.

Breast Cancer Res

Center for Cancer Therapeutics, Ottawa Hospital Research Institute, 501 Smyth Rd, TOHCC 3rd floor, Ottawa, ON, K1H 8L6, Canada.

Published: April 2011

Stress exposure has been proposed to contribute to the etiology of breast cancer. However, the validity of this assertion and the possible mechanisms involved are not well established. Epidemiologic studies differ in their assessment of the relative contribution of stress to breast cancer risk, while physiological studies propose a clear connection but lack the knowledge of intracellular pathways involved. The present review aims to consolidate the findings from different fields of research (including epidemiology, physiology, and molecular biology) in order to present a comprehensive picture of what we know to date about the role of stress in breast cancer development.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219182PMC
http://dx.doi.org/10.1186/bcr2836DOI Listing

Publication Analysis

Top Keywords

breast cancer
16
stress breast
12
molecular biology
8
stress
4
cancer
4
cancer epidemiology
4
epidemiology molecular
4
biology stress
4
stress exposure
4
exposure proposed
4

Similar Publications

Objective.—: To report the isolation and significance of C kroppenstedtii, features of patients with GLM, pathologic findings and mechanism, bacteriologic workup, and optimal treatment.

Design.

View Article and Find Full Text PDF

Objectives: To assess the impact of the transition from film to digital mammography in the Australian national breast cancer screening program.

Study Design: Retrospective linked population health data analysis (New South Wales Central Cancer Registry, BreastScreen NSW); interrupted time series analysis.

Setting: New South Wales, 2002-2016.

View Article and Find Full Text PDF

Background: Nearly 25% of opioid-related deaths are from prescribed opioids, and the exacerbation of the opioid epidemic by the coronavirus disease 2019 (COVID-19) pandemic underscores the urgent need to address superfluous prescribing. Therefore, we sought to align local opioid prescribing practices with national guidelines in postoperative non-metastatic breast cancer patients.

Methods: A single-institution analysis included non-metastatic breast surgery patients treated between April 2020 and July 2021.

View Article and Find Full Text PDF

Recent evidence indicates that endocrine resistance in estrogen receptor-positive (ER+) breast cancer is closely correlated with phenotypic characteristics of epithelial-to-mesenchymal transition (EMT). Nonetheless, identifying tumor tissues with a mesenchymal phenotype remains challenging in clinical practice. In this study, we validated the correlation between EMT status and resistance to endocrine therapy in ER+ breast cancer from a transcriptomic perspective.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!